Prevest Denpro's Technical Indicators Signal Mixed Market Sentiment Amid Performance Fluctuations
2025-04-03 08:06:24Prevest Denpro, a microcap company in the Medical Equipment/Supplies/Accessories industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 482.00, showing a notable increase from the previous close of 464.00. Over the past year, Prevest Denpro has demonstrated a return of 24.03%, significantly outperforming the Sensex, which recorded a return of 3.67% in the same period. In terms of technical indicators, the weekly MACD remains bearish, while the monthly outlook is mildly bearish. The Relative Strength Index (RSI) shows no signal for both weekly and monthly assessments. Bollinger Bands indicate a mildly bearish trend on a weekly basis, with a sideways movement observed monthly. Daily moving averages also reflect a mildly bearish sentiment. The company's performance over various time frames reveals a mixed picture. In the last month, Pr...
Read MorePrevest Denpro Adjusts Valuation Amidst Competitive Medical Equipment Sector Landscape
2025-03-13 08:00:55Prevest Denpro, a microcap player in the medical equipment and supplies sector, has recently undergone a valuation adjustment. The company currently exhibits a price-to-earnings (PE) ratio of 27.47 and a price-to-book value of 5.04, indicating its market valuation relative to its earnings and assets. Additionally, its enterprise value to EBITDA stands at 19.88, while the enterprise value to sales ratio is 6.98. Despite these metrics, Prevest Denpro has faced challenges in its stock performance, with a year-to-date return of -31.69%, contrasting with a modest decline of -5.26% in the Sensex over the same period. Over the past year, the stock has shown a return of 13.04%, which is significantly higher than the Sensex's 0.49% return. In comparison to its peers, Prevest Denpro's valuation metrics reflect a competitive landscape. For instance, BPL and Raaj Medisafe are noted for their attractive valuations, w...
Read MorePrevest Denpro Adjusts Valuation Amidst Competitive Medical Equipment Sector Landscape
2025-03-13 08:00:55Prevest Denpro, a microcap player in the medical equipment and supplies sector, has recently undergone a valuation adjustment. The company currently exhibits a price-to-earnings (PE) ratio of 27.47 and a price-to-book value of 5.04, indicating its market valuation relative to its earnings and assets. Additionally, its enterprise value to EBITDA stands at 19.88, while the enterprise value to sales ratio is 6.98. Despite these metrics, Prevest Denpro has faced challenges in its stock performance, with a year-to-date return of -31.69%, contrasting with a modest decline of -5.26% in the Sensex over the same period. Over the past year, the stock has shown a return of 13.04%, which is significantly higher than the Sensex's 0.49% return. In comparison to its peers, Prevest Denpro's valuation metrics reflect a competitive landscape. For instance, BPL and Raaj Medisafe are noted for their attractive valuations, w...
Read MorePrevest Denpro Shows Resilience Amid Broader Market Decline and Technical Challenges
2025-03-03 10:28:53Prevest Denpro Ltd, a microcap player in the Medical Equipment/Supplies/Accessories industry, has shown notable activity today, with its stock rising by 4.18%. This uptick comes amid a broader market trend, as the Sensex has experienced a decline of 0.37% on the same day. Over the past year, Prevest Denpro has outperformed the Sensex, delivering a return of 11.34% compared to the index's -1.19%. However, the stock has faced challenges in the short term, with a year-to-date performance of -25.46%, while the Sensex has decreased by 6.67% during the same period. The company's market capitalization stands at Rs 527.89 crore, with a price-to-earnings (P/E) ratio of 28.77, significantly lower than the industry average of 57.13. Despite recent fluctuations, the stock's three-year performance shows a gain of 17.28%, although it lags behind the Sensex's 32.35% increase. Technical indicators suggest a bearish t...
Read More
Prevest Denpro Reports Flat Q3 Performance Amidst Valuation Concerns and Low ROCE
2025-02-11 19:14:07Prevest Denpro, a microcap in the Medical Equipment sector, recently experienced a score adjustment reflecting its financial performance. The company reported flat results for Q3 FY24-25, with a low return on capital employed and modest profit growth, while maintaining a low debt-to-equity ratio and healthy long-term growth.
Read MoreClosure of Trading Window
27-Mar-2025 | Source : BSEClosure of Trading window for quarter and financial year ended on March 31 2025
Integrated Filing (Financial)
12-Feb-2025 | Source : BSEIntegrated filing (financial) for the quarter and nine months ended December 31 2024.
Announcement under Regulation 30 (LODR)-Investor Presentation
10-Feb-2025 | Source : BSEInvestor Presentation on the Financial Results for the quarter ended on December 31 2024.
Corporate Actions
No Upcoming Board Meetings
Prevest Denpro Ltd has declared 10% dividend, ex-date: 30 Aug 24
No Splits history available
No Bonus history available
No Rights history available